Innoveren Scientific Overview
- Year Founded
-
2013

- Status
-
Public
- Employees
-
2

- Stock Symbol
-
IVRN

- Investments
-
4
Innoveren Scientific General Information
Description
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
Contact Information
Website
www.hcyte.comCorporate Office
- 2202 North West Shore Boulevard
- Suite 200
- Tampa, FL 33607
- United States
Corporate Office
- 2202 North West Shore Boulevard
- Suite 200
- Tampa, FL 33607
- United States
Innoveren Scientific Stock Performance
As of 27-Jun-2025, Innoveren Scientific’s current market cap is $932.00 with 4.66M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$932.00 | 4.66M | 42.7K |
Innoveren Scientific Financials Summary
As of 30-Sep-2023, Innoveren Scientific has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 30-Sep-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | 6,352 | 5,578 | 12,164 | 29 |
Revenue | 0 | 453 | 1,612 | 2,151 |
EBITDA | (2,815) | (10,425) | (4,607) | (4,915) |
Net Income | (3,259) | (10,300) | (4,799) | (6,459) |
Total Assets | 789 | 137 | 321 | 2,204 |
Total Debt | 4,438 | 3,923 | 3,618 | 1,173 |
Innoveren Scientific Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Innoveren Scientific Patents
Innoveren Scientific Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3407810-A1 | Surgical tools for spinal facet therapy to alleviate pain | Inactive | 29-Jan-2016 | ||
EP-3190997-A1 | Surgical tools with positional components | Active | 12-Dec-2014 | ||
EP-3190997-A4 | Surgical tools with positional components | Active | 12-Dec-2014 | ||
EP-3190997-B1 | Surgical tools with positional components | Active | 12-Dec-2014 | ||
EP-3190997-B8 | Surgical tools with positional components | Active | 12-Dec-2014 | A61B17/8861 |
Innoveren Scientific Signals
Innoveren Scientific Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Innoveren Scientific Acquisitions (4)
Innoveren Scientific’s most recent deal was a Merger/Acquisition with SkinDisc. The deal was made on 22-Dec-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
SkinDisc | 22-Dec-2022 | Merger/Acquisition | Other Healthcare Services | ||
Jantibody | 07-Sep-2022 | Merger/Acquisition | Other Healthcare | ||
Regenerative Medicine Solutions (Pulmonary Biomedical Services and Patient Delivery Platform) | 14-Jan-2019 | Merger/Acquisition | Drug Discovery | ||
Streamline (Healthcare) | 26-Mar-2015 | Merger/Acquisition | Other Devices and Supplies |
Innoveren Scientific FAQs
-
When was Innoveren Scientific founded?
Innoveren Scientific was founded in 2013.
-
Where is Innoveren Scientific headquartered?
Innoveren Scientific is headquartered in Tampa, FL.
-
What is the size of Innoveren Scientific?
Innoveren Scientific has 2 total employees.
-
What industry is Innoveren Scientific in?
Innoveren Scientific’s primary industry is Drug Discovery.
-
Is Innoveren Scientific a private or public company?
Innoveren Scientific is a Public company.
-
What is Innoveren Scientific’s stock symbol?
The ticker symbol for Innoveren Scientific is IVRN.
-
What is the current market cap of Innoveren Scientific?
The current market capitalization of Innoveren Scientific is $932.00.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »